financetom
Business
financetom
/
Business
/
--BBVA Takeover Bid Rejected by Sabadell Shareholders, Bloomberg Reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--BBVA Takeover Bid Rejected by Sabadell Shareholders, Bloomberg Reports
Oct 16, 2025 12:13 PM

02:45 PM EDT, 10/16/2025 (MT Newswires) --

Price: 19.60, Change: +1.34, Percent Change: +7.34

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Enphase Energy Opens Pre-Orders for US-Made Batteries, Microinverters
Enphase Energy Opens Pre-Orders for US-Made Batteries, Microinverters
Aug 27, 2024
08:38 AM EDT, 08/27/2024 (MT Newswires) -- Enphase Energy ( ENPH ) said Tuesday it has launched pre-orders for its US-made IQ Battery 5Ps and IQ8 microinverters that include higher domestic content. The company said the new IQ8 microinverters, made with more US-manufactured components, reduce the need for additional domestic solar equipment to meet the requirements for the Inflation Reduction...
CNX Resources Pick of the Week at Smart Insider Following Director's Stock Purchase
CNX Resources Pick of the Week at Smart Insider Following Director's Stock Purchase
Aug 27, 2024
08:24 AM EDT, 08/27/2024 (MT Newswires) -- CNX Resources ( CNX ) was the stock pick of the week from Smart Insider after a member of the company's board bought 75,000 shares on Aug. 20 at $26.74 apiece. Director Bernard Lanigan's $2 million purchase is indirect for Conifer Partners and increases his total direct and indirect holdings to 1.3 million...
Soleno Therapeutics Says FDA Accepts Application for Prader-Willi Syndrome Drug
Soleno Therapeutics Says FDA Accepts Application for Prader-Willi Syndrome Drug
Aug 27, 2024
08:41 AM EDT, 08/27/2024 (MT Newswires) -- Soleno Therapeutics ( SLNO ) said Tuesday that the US Food and Drug Administration has accepted a new drug application for its experimental drug, DCCR, to treat Prader-Willi syndrome in certain patients four years of age and older. The company said the FDA granted priority review for the new drug application and expected...
Lifezone in Talks With US, Tanzanian Government to Invest in African Mineral Projects
Lifezone in Talks With US, Tanzanian Government to Invest in African Mineral Projects
Aug 27, 2024
08:20 AM EDT, 08/27/2024 (MT Newswires) -- Lifezone Metals ( LZM ) said Tuesday that it is in high-level discussions with the US and Tanzanian Governments to invest in minerals projects in Africa. The metals company said its subsidiary Kabanga Nickel has signed a retainer letter with the US International Development Finance Corporation to begin evaluating political risk insurance coverage...
Copyright 2023-2026 - www.financetom.com All Rights Reserved